Cell Source, Inc.

AI-generated fair value estimate for this company.

Method: Probability-weighted scenario/liquidation model: cash $1,240; total assets $292,446; total liabilities $20,428,481 (including ~$6.33M past-due notes and ~$11.12M past-due convertible notes plus accrued interest); stockholders' deficiency ~-$20.14M; $0 revenue; going-concern doubt disclosed; ~67.95M shares outstanding. 70% probability of default/wind-down ($0/share); 25% probability of a dilutive debt-for-equity restructuring leaving holders ~15% of a reorganized entity worth ~$10M (~$0.022/share); 5% probability of a successful IP licensing breakthrough worth ~$50M to current holders (~$0.74/share). Probability-weighted value ~$0.04/share.

Reasoning: With negative equity, near-zero cash, no revenue, a going-concern qualification, and ~$17.5M of past-due debt, a DCF or multiples approach is not meaningful; a probability-weighted liquidation/restructuring scenario grounded in the actual balance sheet is the only defensible method.